Singapore Strengthens Cybersecurity with OT Masterplan 2024by Lilu Anderson 21.08.2024CSA unveils OT Masterplan 2024 to enhance cybersecurity, focusing on secure deployment and workforce professionalization.
MediWound’s Q2 2024: Strong Growth Amid Challengesby Mark Eisenberg 20.08.2024MediWound Ltd. sees robust Q2 growth with NexoBrid, prepares for global expansion, despite increased financial losses.
ITM Power’s Growth Drives Green Hydrogen Expansionby Mark Eisenberg 19.08.2024ITM Power triples revenue, reduces losses amid growing green hydrogen market demand.
Lendlease Faces $1B Loss Amid Strategic Shiftsby Mark Eisenberg 19.08.2024Lendlease reports $1 billion loss due to strategy overhaul and regulatory delays, impacting its core earnings significantly.
GenScript Biotech Reports Robust Growth in 2024by Mark Eisenberg 19.08.2024GenScript Biotech sees 43.5% revenue rise, expanding global reach and strengthening pipeline.
WPP H1 2024 Results: Key Takeaways and Future Outlookby Mark Eisenberg 18.08.2024WPP faces sales decline but boosts profits with AI and tech focus. Strategic moves include reducing debt and enhancing efficiencies.
Crane NXT Boosts Sales Guidance, Eyes M&A Growthby Mark Eisenberg 18.08.2024Crane NXT lifts full-year sales forecast, reports 5% Q2 growth, and plans strategic acquisitions to reach $3 billion revenue goal.
Adaptimmune Launches Tecelra Amid Strong Q2 Resultsby Mark Eisenberg 18.08.2024Adaptimmune's Tecelra launch marks progress in cell therapy, with strong Q2 financials and strategic plans for cancer treatment.
Genmab Reports 36% Revenue Growth in H1 2024by Mark Eisenberg 15.08.2024Genmab's H1 2024 results show 36% revenue growth; DARZALEX sales surge, and strategic acquisition of ProfoundBio boosts future potential.
Cathie Wood’s Latest Stock Picks: Amazon, Roku, Guardantby Mark Eisenberg 15.08.2024Cathie Wood seizes volatility by investing in Amazon, Roku, and Guardant Health for potential growth amidst market fluctuations.